Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Ratain

Showing results (81-90 of 225) with videos related to

Pageof 23
Sort By:
American Journal of Hematology|January 1, 1988
Rapid response to 2'-deoxycoformycin in advanced hairy cell leukemia after failure of interferons alpha and gammaB C Lembersky, M J Ratain, C Westbrook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Data modifications to phase I study of suraminK Kobayashi, E E Vokes, N J Vogelzang, et al.
American Journal of Clinical Oncology|June 17, 2000
A phase I study of liposomal doxorubicin (Doxil) with topotecanC W Ryan, G F Fleming, L Janisch, et al.
Clinical Pharmacology and Therapeutics|April 18, 2008
Pharmacogenetic pathway analysis of irinotecanG L Rosner, J C Panetta, F Innocenti, et al.
Leukemia & Lymphoma|January 1, 1994
Interferon treatment for hairy cell leukemia. An update on a cohort of 69 patients treated from 1983 to 1986R T Spielberger, R Mick, M J Ratain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersonsE Kodish, C Stocking, M J Ratain, et al.
IRB|November 8, 2001
Quantitative analysis of ethical issues in phase I trials: a survey interview of 144 advanced cancer patientsC K Daugherty, D M Banik, L Janish, et al.
Cancer|April 1, 1993
A phase I study of subcutaneous recombinant interleukin-2 and interferon alfa-2aM J Ratain, E R Priest, L Janisch, et al.
British Journal of Cancer|March 1, 2002
Phase I study of the combination of losoxantrone and cyclophosphamide in patients with refractory solid tumoursB C Goh, E E Vokes, A Joshi, et al.
Cancer Research|July 15, 1988
Limited sampling models for amonafide (NSC 308847) pharmacokineticsM J Ratain, A E Staubus, R L Schilsky, et al.
Pageof 23

Showing results (81-90 of 225) with videos related to

Sort By:
Pageof 23
American Journal of Hematology|January 1, 1988
Rapid response to 2'-deoxycoformycin in advanced hairy cell leukemia after failure of interferons alpha and gammaB C Lembersky, M J Ratain, C Westbrook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Data modifications to phase I study of suraminK Kobayashi, E E Vokes, N J Vogelzang, et al.
American Journal of Clinical Oncology|June 17, 2000
A phase I study of liposomal doxorubicin (Doxil) with topotecanC W Ryan, G F Fleming, L Janisch, et al.
Clinical Pharmacology and Therapeutics|April 18, 2008
Pharmacogenetic pathway analysis of irinotecanG L Rosner, J C Panetta, F Innocenti, et al.
Leukemia & Lymphoma|January 1, 1994
Interferon treatment for hairy cell leukemia. An update on a cohort of 69 patients treated from 1983 to 1986R T Spielberger, R Mick, M J Ratain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersonsE Kodish, C Stocking, M J Ratain, et al.
IRB|November 8, 2001
Quantitative analysis of ethical issues in phase I trials: a survey interview of 144 advanced cancer patientsC K Daugherty, D M Banik, L Janish, et al.
Cancer|April 1, 1993
A phase I study of subcutaneous recombinant interleukin-2 and interferon alfa-2aM J Ratain, E R Priest, L Janisch, et al.
British Journal of Cancer|March 1, 2002
Phase I study of the combination of losoxantrone and cyclophosphamide in patients with refractory solid tumoursB C Goh, E E Vokes, A Joshi, et al.
Cancer Research|July 15, 1988
Limited sampling models for amonafide (NSC 308847) pharmacokineticsM J Ratain, A E Staubus, R L Schilsky, et al.
Pageof 23